[Survival and prognostic factors in radiation and combination therapy of bone metastases of breast cancer].
A retrospective analysis of the survival and mean life rates of 107 patients with breast cancer metastases to the skeletal bones was performed. In non-randomized groups there was no significant correlation of long-term therapeutic results and the type of fractionation, a total radiation dose value, chemo- or hormonotherapy. Prognosis was better in patients in whom solitary metastases were detected 5 and more years after primary treatment. In such cases radiation therapy was indicated at doses sufficient for eradication or stable stabilization of a focus using the most sparing dose fractionation regimens.